We investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, delta variant, ChAdOx1 vaccine, vaccine effectiveness, care home outbreaks, Vaxzevria, B.1.617.2 variant, 【초록키워드】 Vaccine, SARS-COV-2 infection, vaccine dose, COVID-19 outbreak, attack rate, London, Care, SARS-CoV-2 infections, ChAdOx1, AstraZeneca, single dose, ChAdOx1-S, individual, hospitalised, died, investigated, the SARS-CoV-2, 【제목키워드】 COVID-19 vaccine, vaccination, variant, Delta, B.1.617.2, outbreak, London, England, Care, caused, the SARS-CoV-2,
【저자키워드】 COVID-19, SARS-CoV-2, delta variant, ChAdOx1 vaccine, vaccine effectiveness, care home outbreaks, Vaxzevria, B.1.617.2 variant, 【초록키워드】 Vaccine, SARS-COV-2 infection, vaccine dose, COVID-19 outbreak, attack rate, London, Care, SARS-CoV-2 infections, ChAdOx1, AstraZeneca, single dose, ChAdOx1-S, individual, hospitalised, died, investigated, the SARS-CoV-2, 【제목키워드】 COVID-19 vaccine, vaccination, variant, Delta, B.1.617.2, outbreak, London, England, Care, caused, the SARS-CoV-2,
우리는 8/21 거주자와 14/21 직원이 Vaxzevria(ChAdOx1-S; AstraZeneca) 백신 1회 접종을 받은 런던 요양원에서 우려되는 SARS-CoV-2 Delta 변형의 COVID-19 발병을 조사했습니다. 우리는 40명의 개인(19명의 거주자, 21명의 직원) 중 24명의 SARS-CoV-2 감염(16명의 거주자, 8명의 직원)을 확인했습니다. 4명(주민 3명, 직원 1명)이 입원했으며 사망자는 없었다. 1회 백신 접종 후 발병률은 직원 35.7%(5/14), 거주자 81.3%(13/16)였습니다.